[Literature Library] Maternal human milk oligosaccharide (HMO) secretor status, birth mode and infant microbiota development
Gut health
Allergies & Immunity
Nutrition & Disease Management
2 min read
This study found there are differences in infant gut microbiota composition depending on the secretor status of their mothers for human milk oligosaccharides (HMOs) such as 2’-fucosyllactose (2’-FL), as well as birth mode. Microbiota is compromised in caesarean-born infants of non-secretor mothers, potentially leading to increased risk of allergic diseases, and this group may benefit from corrective supplementation such as with bifidobacteria and 2’-FL.
Korpela K, et al. Fucosylated oligosaccharides in mother’s milk alleviate the effects of caesarean birth on infant gut microbiota. Nature. 2018;8:13757.
![[Literature Library] Maternal human milk oligosaccharide (HMO) secretor status, birth mode and infant microbiota development](/sites/default/files/styles/header_image_article_desktop_2x/public/2019-03/03_gastroenterology.jpg.webp?itok=NNQqU2YU)
